Clinical Trial

HIPS Feasibility Randomized Controlled Trial

Study acronym: HIPS-RCT
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to conduct a randomized controlled trial (RCT) to test the feasibility of two dose- and time-matched pain management programs, delivered via live video, for adults with chronic (lasting at least 3 months) and non-arthritic hip-related pain (HRP). Following pre-determined benchmarks, findings from this trial will be used to assess the feasibility, credibility, and acceptability of both programs (HIPS-1, HIPS-2). In preparation for a future clinical trial powered to test efficacy, we will optimize the protocol for patient recruitment, study protocol, and fidelity materials.
Protocol Amendment History 2 changes
critical Recruitment opened 2026-07-11
critical Primary endpoint(s) modified 2026-05-16
Trial Details
NCT Number NCT07586397
Lead Sponsor Massachusetts General Hospital
Collaborators: National Center for Complementary and Integrative Health (NCCIH)
Conditions Hip Pain Chronic, Hip Pain, Physical Medicine and Rehabilitation
Enrollment 50 participants
Start Date 2026-07-20
Primary Completion 2027-12-01 (estimated)
Study Completion 2028-06-01 (estimated)
Updated on ClinicalTrials.gov 2026-08-10